NEOPHARM CO., LTD.

Strumento inattivo

Altre lingue NeoPharm Co., Ltd. Korea S.E.

Azioni

Prezzo di chiusura Korea S.E. Altri mercati azionari
-	-

2023

NeoPharm CO., LTD. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2023

CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

NeoPharm CO., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2023	12/05/23
NeoPharm CO., LTD. announced that it has received KRW 31.970667276 billion in funding	03/06/19
NeoPharm CO., LTD. announced that it expects to receive KRW 31.970667276 billion in funding	24/05/19
Gpower, inc. cancelled the acquisition of 0.27% stake in NeoPharm Co., Ltd. from Byungduk Park.	04/12/18
Gpower, inc. agreed to acquire 0.27% stake in NeoPharm Co., Ltd. from Byungduk Park for approximately KRW 780 million.	08/12/17
HOPE BIOSCIENCES, INC. Acquires Worldwide Rights to Novel MERTK/AXL Inhibitor from Neopharm Co. Ltd	01/02/17
Han Bul Cosmetics Co., Ltd. and an individual completed the acquisition of 29.39% stake in Neopharm Co Ltd from Ahn, Yong-Chan and 7 individuals.	23/06/16
Han Bul Cosmetics Co., Ltd. and an individual signed a contract to acquire 29.39% stake in Neopharm Co Ltd from Yong-Chan Ahn and 7 individuals for KRW 72.8 billion.	07/12/15
Neopharm Co Ltd(KOSDAQ:A092730) added to S&P Global BMI Index	21/09/15
LEO Pharma A/S Enters Supply and Distribution Agreement with NeoPharm Co., Ltd. on Non-Prescription Skin Care Solutions	03/06/15
Neopharm Co Ltd's Equity Buyback announced on February 10, 2014 has expired.	09/02/15
Tranche Update on Neopharm Co Ltd's Equity Buyback Plan announced on February 10, 2014.	12/05/14
Neopharm Co Ltd authorizes a Buyback Plan.	10/02/14
Neopharm Co Ltd announces an Equity Buyback for KRW 1,000 million worth of its shares.	10/02/14
Tranche Update on Neopharm Co Ltd's Equity Buyback Plan announced on July 9, 2013	14/10/13
Neopharm Co Ltd s Equity Buyback announced on July 9, 2013 has expired with 166,483 shares for KRW 1,007.08 million.	09/10/13
Neopharm Co Ltd announces an Equity Buyback	09/07/13

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

I migliori strumenti riservati agli abbonati per incrementare la performance dei tuoi investimenti!

Ottimizzare i miei Profitti

fermer